EF
RPRX icon

Empowered Funds’s Royalty Pharma RPRX Stock Holding History

Empowered Funds’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Buy
232,680
+3,684
+2% +$192K 0.07% 315
2026
Q1 		$11M Sell
228,996
-63,092
-22% -$2.76M 0.07% 345
2025
Q4 		$11.3M Sell
292,088
-5,391
-2% -$206K 0.19% 109
2025
Q3 		$10.5M Buy
297,479
+49,749
+20% +$1.8M 0.11% 211
2025
Q2 		$8.93M Sell
247,730
-9,684
-4% -$321K 0.1% 235
2025
Q1 		$8.01M Buy
+257,414
New +$8.16M 0.11% 220

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Empowered Funds's RPRX Position: Q2 2026 in Review

Empowered Funds increased its Royalty Pharma (RPRX) stake by 1.6% in Q2 2026, buying an estimated $192K and bringing the position to 232,680 shares worth $13M. The position accounts for 0.07% of the portfolio, ranked #315.

Empowered Funds first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Empowered Funds held 232,680 shares of Royalty Pharma worth $13M as of Q2 2026.
  • Empowered Funds bought 3,684 Royalty Pharma shares in Q2 2026, an estimated $192K.
  • Royalty Pharma made up 0.07% of Empowered Funds's portfolio in Q2 2026, its #315 holding.
  • Empowered Funds first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.